Click
Chat
 
Du kan vedhæfte PDF, JPG, PNG, DOC(X), XLS(X) og TXT-filer. Klik på ikonet, vælg fil og vent til upload er færdig før du indsender eller uploader endnu en fil.
60
Vedhæft Send
Historik

Vælg chat via ovenstående menu
Luk reklame

DANMARKS STØRSTE INVESTORSITE MED DEBAT, CHAT OG NYHEDER

Xbrane announces four more patents granted


98114 Aps invest 27/10 2021 15:56
1
Oversigt

Xbrane announces four more patents granted

Xbrane Biopharma AB (publ) (" Xbrane" or the "Company") (Nasdaq Stockholm: XBRANE) has been granted four new patents by the Swedish Patent and Registration Office (PRV). The patents resulted from the development of XdivaneTM (an Opdivo® biosimilar) and form the foundation for a broadening of the platform technology for the production of antibodies with high productivity and thereby low production costs in mammalian cells. This broadening is critical for Xbrane's future portfolio of biosimilars since a majority of biological drugs on the market today are manufactured in mammalian cells.



TRÅDOVERSIGT